← AURORA CANNABIS INC
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Net income (loss) from continuing operations | — | ($300.7m) | ($3.3b) | ($693.5m) | ($1.7b) | — | ($59.0m) | $15.8m | ($58.6m) | — | |
| Net Income | — | — | — | — | ($1.7b) | — | ($69.3m) |
$1.6m
+102.29%
|
($136.0m)
-8645.82%
|
($52.5m)
+61.41%
|
|
| Net Income From Continuing Operations | — | — | — | — | ($1.7b) | — | ($57.1m) | $27.1m | ($58.6m) | ($52.5m) | |
| Profit or Loss | — | ($297.9m) | ($3.3b) | ($695.1m) | ($1.7b) | — | ($69.3m) | $1.6m | — | — | |
| Depreciation of property, plant and equipment | $8.0m | $45.4m | $74.3m | $60.6m | $60.2m | — | $32.2m | $22.0m | $13.4m | $14.0m | |
| Amortization of intangible assets | $4.3m | $42.9m | $40.6m | $37.5m | $33.5m | — | $901k | $595k | $808k | — | |
| Deferred compensation amortization | — | — | — | — | $0 | — | $3.8m | $3.8m | $3.8m | — | |
| Amortization Cash Flow | — | — | — | — | $33.5m | — | $901k | $315k | $808k | — | |
| Amortization Of Intangibles | — | — | — | — | $33.5m | — | $901k | $315k | $808k | $737k | |
| Depreciation | — | — | — | — | $60.2m | — | $31.9m | $12.3m | $13.4m | $13.3m | |
| Depreciation Amortization Depletion | — | — | — | — | $93.7m | — | $32.8m | $12.6m | $14.2m | $14.0m | |
| Deferred tax recovery (expense) | $6.4m | ($23.3m) | ($78.3m) | ($6.4m) | ($2.2m) | — | ($1.7m) | ($3.2m) | $55k | — | |
| Deferred Income Tax | — | — | — | — | ($2.2m) | — | ($1.7m) | ($3.2m) | $55k | ($146k) | |
| Adjustments For Share-Based Payments | — | $107.0m | $59.9m | $20.2m | $13.8m | — | $12.7m | $11.5m | — | — | |
| Share-based compensation | $37.5m | $107.0m | $59.9m | $20.2m | $13.8m | — | $12.7m | $11.5m | $7.3m | $5.8m | |
| Impairment of intangible assets and goodwill | $0 | $9.0m | $2.5b | $44.9m | $1.2b | — | $32.9m | $0 | $13.2m | — | |
| Asset Impairment Charge | — | — | — | — | $1.5b | — | $36.9m | $696k | $16.0m | $567k | |
| Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method | — | — | — | — | $0 | — | $5.0m | $5.5m | — | — | |
| Change In Working Capital | — | — | — | — | $52.7m | — | ($15.5m) | $14.2m | ($9.2m) | ($9.3m) | |
| Change In Receivables | — | — | — | — | $18.3m | — | ($4.5m) | $4.2m | ($8.1m) | ($7.7m) | |
| Changes In Account Receivables | — | — | — | — | $18.3m | — | ($4.5m) | $4.2m | ($8.1m) | ($7.7m) | |
| Changes in fair value of inventory and biological assets sold | — | — | — | — | — | — | $80.7m | $141.8m | $138.3m | — | |
| Change In Inventory | — | — | — | — | $21.1m | — | $3.9m | ($2.0m) | $7.4m | $10.3m | |
| Change In Other Current Liabilities | — | — | — | — | $1.6m | — | ($25k) | — | — | ($88k) | |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $0 | $0 | $3.7m | $19.2m | $19.6m | — | $12.3m | $2.0m | $1.1m | — | |
| Purchase of property, plant and equipment and intangible assets | ($136.9m) | ($414.3m) | ($355.0m) | ($53.1m) | ($32.2m) | — | ($17.0m) | ($18.9m) | ($22.5m) | — | |
| Purchase of short-term investments | ($63.4m) | ($50.6m) | ($2.0m) | ($6.7m) | $0 | — | — | $0 | ($52.2m) | — | |
| Proceeds from disposal of marketable securities | $0 | $47.0m | $90.8m | $18.1m | $0 | — | $5.0m | $5.5m | $0 | — | |
| Net Other Investing Changes | — | — | — | — | ($185k) | — | $2.1m | ($4.3m) | $818k | $818k | |
| Cash provided by (used in) investing activities from continuing operations | — | — | — | — | — | — | ($3.0m) | ($15.6m) | ($72.8m) | — | |
| Net cash provided by (used in) investing activities from discontinued operations | — | ($109k) | $8.4m | $1.5m | $0 | — | ($255k) | $1.3m | $235k | ($66.7m) | |
| Net cash provided by (used in) investing activities | ($536.9m) | ($312.3m) | ($249.5m) | ($26.9m) | ($36.6m) | — | ($5.5m) | ($14.3m) | ($72.6m) | ($66.7m) | |
| Repayments Of Borrowings Classified As Financing Activities | — | — | — | — | $0 | — | $3.0m | $7.2m | — | — | |
| Issuance Of Debt | — | — | — | — | $0 | — | $14.5m | $11.7m | — | $11.0m | |
| Long Term Debt Issuance | — | — | — | — | $0 | — | $14.5m | $11.7m | — | $11.0m | |
| Long Term Debt Payments | — | — | — | — | ($170.8m) | — | ($99.9m) | ($5.2m) | ($5.0m) | ($5.1m) | |
| Net Issuance Payments Of Debt | — | — | — | — | ($170.8m) | — | ($85.4m) | ($5.2m) | ($5.0m) | ($5.1m) | |
| Net Long Term Debt Issuance | — | — | — | — | ($170.8m) | — | ($85.4m) | ($5.2m) | ($5.0m) | ($5.1m) | |
| Repayment Of Debt | — | — | — | — | ($170.8m) | — | ($99.9m) | ($5.2m) | ($5.0m) | ($5.1m) | |
| Common Stock Issuance | — | — | — | — | $350.2m | — | $37.9m | $0 | $10.9m | $17.8m | |
| Issuance Of Capital Stock | — | — | — | — | $350.2m | — | $37.9m | $0 | $10.9m | $17.8m | |
| Net Other Financing Charges | — | — | — | — | ($31.6m) | — | — | — | ($1.6m) | ($1.8m) | |
| Cash provided by (used in) financing activities from continuing operations | — | — | — | — | — | — | ($47.4m) |
$15k
+100.03%
|
$4.9m
+32540.00%
|
— | |
| Net cash provided by (used in) financing activities from discontinued operations | — | $0 | ($137k) |
($331k)
-141.61%
|
$0
+100.00%
|
— | ($89k) |
($131k)
-47.19%
|
$4.9m
+3813.74%
|
$11.4m
+135.03%
|
|
| Net cash provided by (used in) financing activities | $535.2m |
$597.5m
+11.66%
|
$582.6m
-2.51%
|
$522.0m
-10.40%
|
$147.8m
-71.69%
|
— | ($47.9m) |
($116k)
+99.76%
|
$9.8m
+8514.66%
|
$11.4m
+17.14%
|
|
| Increase (decrease) in cash and cash equivalents | ($83.0m) | $95.9m | ($10.5m) | $259.3m | $16.4m | — | ($121.6m) | $1.8m | ($73.2m) | — | |
| Cash and cash equivalents, beginning of period | $76.8m | $172.7m | $162.2m | $421.5m | $437.8m | $234.9m | $113.4m | $137.9m | $64.7m | — | |
| Beginning Cash Position | — | — | — | — | $421.5m | — | $255.6m | $136.1m | $137.9m | $140.2m | |
| Changes in restricted cash | ($13.4m) | ($32.7m) | $46.1m | — | — | — | $2.1m | ($4.3m) | $818k | — | |
| Effect Of Exchange Rate Changes | — | — | — | — | $15.0m | — | $297k | $264k | $3.1m | $5.1m | |
| Additional Supplementary Disclosures | |||||||||||
| Additional Supplementary Disclosures | |||||||||||
| Additional Financial Items | |||||||||||
| Adjustments For Unrealised Foreign Exchange Losses Gains | — | ($3.8m) | $12.8m | $3.4m | ($1.9m) | — | $105k | ($11.5m) | — | — | |
| General And Administrative Expense | — | $172.4m | $205.3m | $119.4m | $113.2m | — | $92.2m | $97.3m | — | — | |
| Goodwill | — | $3.2b | $928.4m | $887.7m | $0 | — | $43.2m | $43.9m | — | $567k | |
| Increase Decrease In Working Capital | — | $38.0m | ($7.6m) | ($397k) | ($52.7m) | — | $15.6m | ($10.2m) | — | ($9.3m) | |
| Interest Paid Classified As Financing Activities | — | $18.1m | — | — | $27.7m | — | $14.9m | $2.9m | $2.4m | — | |
| Interest Paid Classified As Operating Activities | — | — | $47.9m | $34.2m | $27.7m | — | $11.7m | $6.8m | $2.4m | — | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | $0 | $7.8m | $5.4m | $7.5m | — | $5.6m | $5.2m | $5.0m | — | |
| Proceeds From Issuing Shares | — | $59.3m | $575.5m | $666.0m | $350.2m | — | $37.9m | $0 | — | — | |
| Unrealized gain on changes in fair value of biological assets | ($25.6m) | ($96.5m) | ($56.6m) | ($109.2m) | ($118.7m) | — | ($134.6m) | ($175.4m) | ($116.1m) | — | |
| Net interest accrual and accretion | $9.7m | $22.8m | $18.6m | $30.5m | $30.1m | — | $8.3m | $2.5m | ($1.1m) | — | |
| Other gains (losses) | ($183.4m) | ($109.5m) | $28.6m | ($10.6m) | ($39.6m) | — | ($29.1m) | ($607k) | ($720k) | — | |
| Foreign exchange gain (loss) | $0 | ($3.8m) | $12.8m | $3.4m | ($1.9m) | — | $105k | ($11.5m) | ($1.6m) | — | |
| Changes in non-cash working capital | ($25.4m) | ($38.0m) | $7.6m | $397k | $50.0m | — | ($15.6m) | $10.2m | ($9.2m) | — | |
| Net principal payments of lease liabilities | — | $0 | ($7.8m) | ($5.4m) | ($7.5m) | — | ($5.6m) | ($5.2m) | ($5.0m) | — | |
| Proceeds from issuance of shares | $215.6m | $59.3m | $575.5m | $666.0m | $350.2m | — | $37.9m | $0 | $10.9m | — | |
| Share issuance costs | — | — | — | — | — | — | — | $0 | ($1.6m) | — | |
| Proceeds from stock option exercise | — | — | — | — | — | — | $0 | $820k | $587k | $557k | |
| Effect of foreign exchange on cash and cash equivalents | $355k | $2.9m | ($5.7m) | ($25.2m) | $15.0m | — | $297k | $264k | $3.1m | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | $147.8m | — | ($47.4m) | ($4.4m) | $4.9m | $11.4m | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | ($36.2m) | — | ($3.0m) | ($11.9m) | ($72.8m) | ($66.7m) | |
| Cash From Discontinued Financing Activities | — | — | — | — | $0 | — | ($475k) |
$4.3m
+1006.11%
|
$4.9m
+13.03%
|
$7.0m
+44.40%
|
|
| Cash From Discontinued Investing Activities | — | — | — | — | $0 | — | ($377k) | ($2.5m) | $235k | $394k | |
| Change In Account Payable | — | — | — | — | $6.8m | — | ($15.7m) | $7.1m | ($8.0m) | ($13.3m) | |
| Change In Cash Supplemental As Reported | — | — | — | — | $16.4m | — | ($119.5m) | $1.8m | ($73.2m) | — | |
| Change In Income Tax Payable | — | — | — | — | $331k | — | $1.2m | $7.9m | ($187k) | $1.0m | |
| Change In Other Working Capital | — | — | — | — | $1.9m | — | $108k | ($1.2m) | $490k | $226k | |
| Change In Payable | — | — | — | — | $7.1m | — | ($14.5m) | $15.0m | ($8.2m) | ($13.3m) | |
| Change In Prepaid Assets | — | — | — | — | $2.7m | — | ($548k) | ($1.8m) | ($763k) | $126k | |
| Change In Tax Payable | — | — | — | — | $331k | — | $1.2m | $7.9m | ($187k) | $1.0m | |
| Changes In Cash | — | — | — | — | $1.3m | — | ($119.8m) | $1.6m | ($76.4m) | ($76.0m) | |
| End Cash Position | — | — | — | — | $437.8m | — | $136.1m | $137.9m | $64.7m | $64.2m | |
| Financing Cash Flow | — | — | — | — | $147.8m | — | ($47.9m) |
($116k)
+99.76%
|
$9.8m
+8514.66%
|
$11.4m
+17.14%
|
|
| Free Cash Flow | — | — | — | — | ($142.5m) | — | ($85.3m) | $952k | ($36.1m) | ($51.2m) | |
| Income Tax Paid Supplemental Data | — | — | — | — | — | — | $0 | $928k | $759k | $759k | |
| Investing Cash Flow | — | — | — | — | ($36.2m) | — | ($3.4m) | ($14.3m) | ($72.6m) | ($66.7m) | |
| Net Business Purchase And Sale | — | — | — | — | ($23.4m) | — | ($5.5m) | $0 | — | $0 | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | — | ($1.9m) | — | $171k | ($11.5m) | ($1.6m) | ($4.7m) | |
| Net Investment Purchase And Sale | — | — | — | — | $0 | — | $5.0m | $5.5m | ($52.2m) | ($30.7m) | |
| Net PPE Purchase And Sale | — | — | — | — | ($12.6m) | — | ($4.6m) | ($13.1m) | ($21.4m) | ($22.0m) | |
| Operating Gains Losses | — | — | — | — | ($1.9m) | — | $171k | ($11.5m) | ($1.6m) | ($4.7m) | |
| Other Non Cash Items | — | — | — | — | ($22.6m) | — | ($71.4m) | ($32.4m) | $24.1m | — | |
| Purchase Of Business | — | — | — | — | ($23.4m) | — | ($5.5m) | $0 | — | $0 | |
| Purchase Of Investment | — | — | — | — | $0 | — | — | $0 | ($52.2m) | ($52.2m) | |
| Purchase Of PPE | — | $414.3m | $349.1m | $50.3m | ($32.2m) | — | ($16.8m) | ($15.1m) | ($22.5m) | ($23.1m) | |
| Sale Of Investment | — | — | — | — | $0 | — | $5.0m | $5.5m | $0 | $21.5m | |
| Sale Of PPE | — | — | — | — | $19.6m | — | $12.3m | $2.0m | $1.1m | $777k | |
| Stock Based Compensation | — | — | — | — | $13.8m | — | $12.7m | $11.5m | $7.3m | $5.8m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.